MGX Stock Analysis: Buy, Sell, or Hold?
MGX - Metagenomi, Inc. Common Stock
$1.24
-0.05 (-3.88%)
▼
5d:
-1.59%
30d:
+5.98%
90d:
-13.89%
BUY
HIGH Confidence
Analysis Updated: Jul 16, 2026 12:00 AM ET
Earnings: Aug 11, 2026
24d
Get Alerted When MGX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: MGX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: MGX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: MGX is currently trading at $1.24, which is considered fair relative to its 30-day fair value range of $1.19 to $1.28.
Technical Outlook: Technically, MGX is in a downtrend. Immediate support is located at $1.17, while resistance sits at $1.36. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: MGX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.00 (+442.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MGX is in a downtrend. Immediate support is located at $1.17, while resistance sits at $1.36. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: MGX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.00 (+442.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.19 -
$1.28
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
81.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.9%)
- BULLISH: Trading 442.6% below Wall St target ($7.00)
Trading Range Analysis
30-Day Trading Range
$1.19 -
$1.28
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.17
Resistance Level
$1.37
Current Trend
Downtrend
Technical data as of
Jul 16, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.71
Wall Street Target
$7.00
(+442.6%)
Revenue Growth (YoY)
-69.8%
Share & Embed Analysis
Last updated: July 16, 2026 8:13 PM ET
Data refreshes hourly during market hours. Next update: 9:13 PM
Data refreshes hourly during market hours. Next update: 9:13 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MGX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Pamela Wapnick
SELL
1581 shares
2026-03-05
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 61 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$277 | 59 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 52 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 52 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$111 | 57 HOLD |
